Related Experiment Video
Updated: Mar 19, 2026
10:31
Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers
Published on: September 29, 2017
10.8K
Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
M I G Lopez Sanchez1, J G Crowston1, D A Mackey2
1Centre for Eye Research Australia, 75 Commercial Road, Melbourne, 3004, Victoria, Australia; Ophthalmology, University of Melbourne, Department of Surgery, Australia.
Pharmacology & Therapeutics
|June 12, 2016
Summary
Mitochondrial dysfunction causes optic neuropathies like Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA), leading to vision loss. Research explores new therapies for these conditions and glaucoma.
Area of Science:
- Neuroscience
- Ophthalmology
- Mitochondrial Biology
Background:
- Optic neuropathies are a leading cause of global blindness.
- Mitochondrial dysfunction is implicated in retinal ganglion cell degeneration.
- Inherited optic neuropathies, Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA), underscore the role of mitochondrial health.
Purpose of the Study:
- To review mitochondrial biology's role in retinal ganglion cell function.
- To overview major optic neuropathies with mitochondrial involvement (LHON, ADOA).
- To highlight the link between mitochondrial dysfunction and glaucoma, and discuss therapeutic strategies.
Main Methods:
- Literature review of mitochondrial biology and optic neuropathies.
- Analysis of pathogenesis mechanisms in retinal ganglion cells.
- Examination of current and emerging therapeutic strategies.
Main Results:
- Mitochondrial dysfunction is a key factor in optic nerve diseases and neurodegeneration.
- Retinal ganglion cells are particularly susceptible to mitochondrial impairment.
- Emerging evidence links mitochondrial dysfunction to glaucoma pathogenesis.
Conclusions:
- Understanding mitochondrial dysfunction in optic neuropathies is crucial for developing treatments.
- New therapeutic strategies, including gene correction, are under investigation.
- Insights from optic neuropathies may inform treatments for age-related neurodegenerative diseases.
